UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 29, 2010
AURA BIO CORP.
(Exact name of registrant as specified in charter)
Nevada | 333-157558 | 68-0677348 |
(State or other jurisdi ction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
848 N. Rainbow Blvd. #2167 Las Vegas, NV 89107 | 89107 |
(Address of principal executive offices) | (Zip Code) |
(415) 504-3659
Registrant’s telephone number
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
o Pre-commencement co mmunications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 1.02. Terminaton of a Material Definitive Agreement.
On September 29, 2010, the Board of Directors of Aura Bio Corp. (the “Company”) resolved to terminate the purchase agreement that it had previously entered into with Tolao Energy Nigeria Limited (the “Agreement”). Pursuant to the Agreement, the Company had the right to earn a 10% working interest in a proposed Agricultural Biodiesel project in Cross River State, Nigeria if it made certain payments. The Company had decided not to proceed with such payments.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AURA BIO CORP. | ||
Date: September 29, 2010 |
| By: /s/ Harry Lappa |
|
| Harry Lappa, President |
|
|
|